Premium-grade activated sugars & glycoenzymes – without premium prices.

In Vitro Glycoengineering on monoclonal antibodies Competitor price match.

In stock. Bulk ready. Expert support.

DIE VISION

At eversyn, we’re tackling this challenge head-on, leveraging cutting-edge biotechnology to make these vital molecules accessible at both R&D and industrial scales. By bridging this gap, we aim to unlock the full potential of glycans, paving the way for groundbreaking discoveries and innovations in nutrition and biopharma.

Das Team

 

 

Rachel Thu  Nguyen, Gründerin

Rachel Thu Nguyen, Gründerin

Dr. Thomas Rexer, Gründer

Dr. Thomas Rexer, Gründer

Dr. Nam-Hai Hoang, Gründer

Dr. Nam-Hai Hoang, Gründer

LUST AUF MEHR STORYS?